What is Unicorn Biosciences?

Unicorn Biosciences specializes in cutting-edge cellular therapies, offering a promising alternative approach for orthopedic injuries. Our focus is on utilizing the latest advancements in cellular sciences to develop personalized plans tailored to each patient’s unique needs. By harnessing the regenerative potential of cells, we aim to enhance the body’s natural healing processes and deliver optimal results, helping patients recover more effectively from joint, bone, and soft tissue injuries. With a commitment to innovative, patient-centered care, Unicorn Biosciences strives to lead the way in transforming how we care for orthopedic injuries.

Our Goal

Cellular therapy is an exciting and rapidly advancing field of medicine that involves the use of cells, proteins and growth factor to promote natural healing diseases and injuries. Each type of cellular therapy can vary significantly depending on the specific condition being treated. The FDA plays a critical role in ensuring that new cellular therapy products are both safe and effective before they become available on the market. Unicorn Biosciences is at the forefront of this innovation, working to deliver cutting-edge therapies that adhere to strict safety standards. Staying informed about new developments in this field can help patients and healthcare providers make better decisions about available treatment options. We are here for you!

Explore our team and learn more about how we are leading the way in regenerative medicine for orthopedic care. We are here to support you on your journey to healing.

Our Team at Unicorn Biosciences

At Unicorn Biosciences, we are dedicated to advancing orthopedic care with the latest in cellular therapies. Our skilled team combines years of expertise in orthopedics and cellular sciences to deliver safe, effective, and personalized treatment plans. Led by highly experienced medical professionals, Unicorn Biosciences is pioneering a transformative approach to healing orthopedic injuries by tapping into the regenerative potential of cellular therapies.

Dr. Aldaas
Dr. AldaasCEO / Founder
Dr. Aldaas is a board-certified physician with over a decade of experience in hospital medicine. He earned his medical degree from St. Matthew’s University School of Medicine and completed his residency in Family Medicine at Ellis Hospital. In addition to his clinical practice, Dr. Aldaas serves as an Assistant Professor of Medicine at Albany Medical Center, where he is involved in medical education and mentoring the next generation of physicians.
Josh Simpson, MS-PAC
Josh Simpson, MS-PACTechnical Manager
Josh trained in Orthopedic Surgery at Johns Hopkins and has extensive experience working at the prestigious Hospital for Special Surgery in orthopedic trauma. With a background in hair restoration, Josh brings a unique blend of expertise in both regenerative medicine and orthopedic care, making him an invaluable asset to our team. His dedication to precision and patient-centered care reflects Unicorn Biosciences’ mission to provide the best in cellular therapy.
Dr. Roy Stoller
Dr. Roy StollerAdvisor
Dr. Roy Stoller is a board-certified facial plastic surgeon with over 25 years of experience specializing in hair restoration. A founding member of the International Society of Hair Restoration Surgery, he has helped advance key innovations in FUE and regenerative therapies. At Unicorn Bioscience, Dr. Stoller contributes his deep clinical expertise and commitment to excellence in patient care, supporting the development of personalized, science-driven solutions for hair loss. His work reflects Unicorn’s mission to bridge cutting-edge technology with real-world treatment outcomes.
Dr. Glenn M. Charles
Dr. Glenn M. CharlesAdvisor
Dr. Glenn Charles is a renowned hair transplant surgeon with decades of experience and a legacy of leadership as a past president of the ISHRS. Known for his meticulous surgical approach and dedication to natural results, he brings hands-on clinical insight to Unicorn Bioscience. His expertise in both surgical technique and patient-focused care plays a key role in guiding the practical application of Unicorn’s regenerative technologies. Dr. Charles’ contributions ensure our innovations are grounded in clinical reality and driven by meaningful patient outcomes.